IEMG vs XBI
iShares Core MSCI Emerging Markets ETF vs SPDR S&P Biotech ETF
- • IEMG has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • IEMG pays a higher dividend yield (2.37%).
Side-by-side metrics
| Metric | IEMG | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.37% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $151.17B | $8.30B |
YTD return | 22.81% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.99 | 1.09 |
P/E ratio | 17.04 | — |
Last price | $81.47 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
IEMG top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 12.49% |
| 005930.KS | Samsung Electronics Co Ltd | 5.32% |
| 000660.KS | SK Hynix Inc | 3.51% |
| 0700.HK | Tencent Holdings Ltd | 2.87% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 2.11% |
| 2308.TW | Delta Electronics Inc | 0.98% |
| 2454.TW | MediaTek Inc | 0.91% |
| 00939 | China Construction Bank Corp Class H | 0.81% |
| HDFCBANK.NS | HDFC Bank Ltd | 0.69% |
| RELIANCE.NS | Reliance Industries Ltd | 0.67% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About IEMG
IEMG (iShares Core MSCI Emerging Markets ETF) is Broad emerging-market equity exposure. Managed by iShares, the fund carries $151.2B in assets under management, an expense ratio of 0.09%, a dividend yield of 2.37%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 12.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.7%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.